Stocks and Investing Stocks and Investing
Thu, March 16, 2023

Constantine Davides Reiterated (VNRX) at Strong Buy and Held Target at $6 on, Mar 16th, 2023


Published on 2024-10-28 02:17:56 - WOPRAI, Constantine Davides
  Print publication without navigation


Constantine Davides of EF Hutton, Reiterated "VolitionRx Limited" (VNRX) at Strong Buy and Held Target at $6 on, Mar 16th, 2023.

Constantine has made no other calls on VNRX in the last 4 months.



There is 1 other peer that has a rating on VNRX. Out of the 1 peers that are also analyzing VNRX, all agrees with Constantine's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Bruce Jackson of "Benchmark" Downgraded from Strong Buy to Hold on, Wednesday, February 1st, 2023

Contributing Sources